Health Care & Life Sciences » Biotechnology | Actinogen Medical Ltd.

Actinogen Medical Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
20.00
-
-
-
-
Cost of Goods Sold (COGS) incl. D&A
13.60
221.40
365.30
360.60
356.00
Gross Income
6.40
221.40
365.30
360.60
356.00
SG&A Expense
584.60
5,356.60
7,214.90
4,236.70
9,206.30
EBIT
578.20
5,578.00
7,580.30
4,597.30
9,562.30
Unusual Expense
22.50
1.50
-
-
-
Non Operating Income/Expense
146.20
98.60
93.90
109.70
135.00
Pretax Income
440.20
5,431.00
7,382.20
4,450.10
9,388.60
Income Tax
-
-
3,748.50
1,259.70
3,158.00
Consolidated Net Income
440.20
5,431.00
3,633.80
3,190.30
6,230.60
Net Income
440.20
5,431.00
3,633.80
3,190.30
6,230.60
Net Income After Extraordinaries
440.20
5,431.00
3,633.80
3,190.30
6,230.60
Net Income Available to Common
440.20
5,431.00
3,633.80
3,190.30
6,230.60
EPS (Basic)
0.00
0.01
0.01
0.01
0.01
Basic Shares Outstanding
152,632.50
412,406.90
606,240.40
609,010.00
705,094.10
EPS (Diluted)
0.00
0.01
0.01
0.01
0.01
Diluted Shares Outstanding
152,632.50
412,406.90
606,240.40
609,010.00
705,094.10
EBITDA
564.60
5,356.60
7,214.90
4,236.70
9,206.30
Non-Operating Interest Income
14.30
49.90
104.20
37.50
38.70

About Actinogen Medical

View Profile
Address
109 Pitt Street
Sydney New South Wales (NSW) 2000
Australia
Employees -
Website http://www.actinogen.com.au
Updated 07/08/2019
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders. The company was founded by David Keast on March 23, 1999 and is headquartered in West Perth, Australia. .